Vontobel Financial Products GmbH (F17508) Quote

Sure, and IF that happens SFRX should do…….

all they can to put a stop to it.

In fact, they “alleged” such about an Ihub member almost 10 years ago, but they have yet to move the case forward.

There’s another hearing next week in the matter. The Judge i

In case anyone forgot...
https://eda.wv.gov/wp-content/uploads/2024/03/Clean-Vision-Corp.-Final-Approval.pdf

I told you....YES..... if a certain criteria is met. Pay attention!

All I have is time and this one I’ve been holding for a loooong time RNAZ if you want to print money….. watch it!

IART

Another Huge Insider buy today reported. This time almost a 1.5 million buy by the chairman. This kind of buying I see as huge plus. All is just my opinion, and I could always be wrong though.

aapj to a dime on coming pr progress imo

Lotsa folks here saying they're prepared to go Long if that's what it takes.....I think you're going to have lots of time, unfortunately.

I honestly don't understand why some Longs feel they have to pump it over and over and over then always blame the MM's or the shorts or the bashers

How to Tie a Noose
Need a Hand Man's Noose

https://www.youtube.com/watch?v=MRPBaGzVZwo

The fallacy of the nine figure revenue projection was bad enough. But now she's once again promoting the short conspiracy in the stock.

GMSacha Inchi $QEDN
@GMSachaInchi
·
23h
$QEDN was one of the three most shortest shares on OTC. QEDN is expanding and giv

longrider51, Good comment, and post. Guess you know conix isn't really interested in any specific answer or else she could have contributed something as you did. She has her spoon and her fork. They seem to serve what appears, particularly today, to be her basic motives for being here.

Just an aside to the Lab tour. We were told the board had a major discussion on whether or not to have us sign NDA’s for the lab tour as they make all others who tour the lab and in the end decided against it but did sequester our phones. As a result the engineers and scientists we spoke to had to

Must be major news on the horizon. Let's see if it can break the .20 in volume on Tuesday. This mess is ready for the morgue.

Maybe if they fall down to triples 000 I can buy some

https://www.kereport.com/2024/05/23/luca-mining-production-development-and-exploration-updates-at-the-campo-morado-and-tahuehueto-mines/

Preferred shares that are restricted are included in outstanding shares.

They were issued to the employees.

There are 3,333,646,557 Outstanding Shares - plenty to pass around to Cooley and Sanchez.

IG

I'm not sure I agree with you, the saying goes... Buy the rumor and sell the news. To be honest the stock handled itself the way I thought it would and I wasn't disappointed with today's movement, I also was able to pick up more shares @ 0.0073.

The win has to be overwhelming in Trump's favor.

Ask Facts fraud why she doesn’t want people to know someone made over one million dollars clear after the cost of buying was taken off.

She won’t answer. She knows it’s true. All the evidence was shared plain as day.

Fact fraud as usual, hiding.

Fact clo

To be fair and balanced, this the company’s response:

https://www.greenmarketreport.com/mj-link-decentral-ask-court-to-dismiss-the-investor-case-against-them/

Case still pending.

The only trane deal is the one coming at you behind the headlight in the endless tunnel you are in, BOOM.

On a good day I will give him a count of up to 1000, it is a great aerial shot.................

https://www.msn.com/en-us/news/politics/overhead-shot-of-trump-s-bronx-rally-tells-a-different-story-about-crowd-size/ar-BB1mZ34C?ocid=BingNewsSerp

I’m sorry you didn’t listen, I post facts. Calling the honest folks who do so, “paid bashers”, is not cool. That’s a bit malicious and 100% false.

I realize you were negative when you first showed up here, debating with “Moving On” - I posted to you. But it appears Twitter pumper, “

When's the divorce?

Clinical trial expected to commence in mid-2024 to evaluate the safety and preliminary anti-tumor activity of TTX-MC138
BOSTON, April 15, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA ther

TransCode Therapeutics, Inc. (Nasdaq: RNAZ) has received notice from the Nasdaq Stock Market LLC that it has regained compliance with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1) for continued listing. The company will be subject to a mandatory panel monitor thro